We are live on ! Find out more
HSA

Hussman Strategic Advisors Portfolio holdings

AUM $463M
1-Year Est. Return 16%
This Fund
S&P 500
This Quarter Est. Return
+9.5%
1 Year Est. Return
+16%
3 Year Est. Return
+35.45%
5 Year Est. Return
+32.62%
10 Year Est. Return
+255.18%
AUM
$1.4B
AUM Growth
-$416M
Cap. Flow
-$548M
Cap. Flow %
-39.01%
Top 10 Hldgs %
15.67%
Holding
242
New
35
Increased
45
Reduced
67
Closed
45

Top Buys

Rank Stock Value
1
GSK icon
GSK
GSK
+$20.7M
2
CVX icon
Chevron
CVX
+$20.7M
3
STJ
St Jude Medical
STJ
+$20.3M
4
LH icon
Labcorp
LH
+$19.9M
5
MCD icon
McDonald's
MCD
+$19.2M

Top Sells

Rank Stock Value
1
AFL icon
Aflac
AFL
+$29.5M
2
CL icon
Colgate-Palmolive
CL
+$23.7M
3
GNRC icon
Generac Holdings
GNRC
+$23.2M
4
MUR icon
Murphy Oil
MUR
+$21.9M
5
MAT icon
Mattel
MAT
+$20.4M

Sector Composition

Rank Sector Weight
1 Healthcare 20.9%
2 Technology 18.98%
3 Consumer Discretionary 12.11%
4 Consumer Staples 9.66%
5 Industrials 7.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HMY icon
126
Harmony Gold Mining
HMY
$9.84B
$1.26M 0.09%
500,000
SNY icon
127
Sanofi
SNY
$103B
$1.19M 0.08%
22,100
DMC
128
Del Monte Corp
DMC
$1.41B
$1.13M 0.08%
+40,000
New +$1.13M
BVN icon
129
Compañía de Minas Buenaventura
BVN
$7.69B
$1.12M 0.08%
100,000
BSTG
130
DELISTED
Biostage, Inc. Common Stock
BSTG
$1.1M 0.08%
+232,500
New +$1.09M
TSM icon
131
TSMC
TSM
$2.1T
$959K 0.07%
55,000
AEO icon
132
American Eagle Outfitters
AEO
$2.88B
$893K 0.06%
+62,000
New +$920K
NZT
133
DELISTED
TELECOM CORP NEW ZEALAND ADS (EACH REPRESENTING 5 ORD SHS)
NZT
$877K 0.06%
92,500
MR
134
DELISTED
MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A
MR
$818K 0.06%
22,500
GFI icon
135
Gold Fields
GFI
$29B
$800K 0.06%
250,000
NGG icon
136
National Grid
NGG
$80.4B
$686K 0.05%
10,884
RENX
137
DELISTED
RELX N.V.
RENX
$644K 0.05%
46,433
NTES icon
138
NetEase
NTES
$85.3B
$629K 0.04%
40,000
SBSW icon
139
Sibanye-Stillwater
SBSW
$6.26B
$572K 0.04%
126,235
GG
140
DELISTED
Goldcorp Inc
GG
$542K 0.04%
25,000
-75,000
-75% -$1.76M
TPR icon
141
Tapestry
TPR
$30.8B
$533K 0.04%
9,500
+7,000
+280% +$378K
PG icon
142
Procter & Gamble
PG
$336B
$529K 0.04%
6,500
-200,000
-97% -$16.3M
WMT icon
143
Walmart Inc
WMT
$885B
$527K 0.04%
20,100
LLY icon
144
Eli Lilly
LLY
$1.02T
$510K 0.04%
10,000
KDP icon
145
Keurig Dr Pepper
KDP
$42.3B
$487K 0.03%
10,000
+2,000
+25% +$94.2K
EPIQ
146
DELISTED
EPIQ SYSTEMS INC
EPIQ
$486K 0.03%
30,000
+20,000
+200% +$304K
VCI
147
DELISTED
VALASSIS COMMUNICATIONS INC
VCI
$480K 0.03%
14,000
-101,000
-88% -$2.99M
MXIM
148
DELISTED
Maxim Integrated Products
MXIM
$474K 0.03%
17,000
+12,500
+278% +$361K
KSS icon
149
Kohl's
KSS
$2.17B
$471K 0.03%
8,300
+1,000
+14% +$54.8K
ESV
150
DELISTED
Ensco Rowan plc
ESV
$457K 0.03%
2,000
+750
+60% +$173K

Similar funds

Hussman Strategic Advisors's Q4 2013 Portfolio in Review

As of Q4 2013, Hussman Strategic Advisors held 242 positions worth $1.4B, down 23% from $1.82B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Hussman Strategic Advisors withdrew a net $548M in Q4 2013, closing 45 positions and reducing 67 holdings. Its most notable exit was Colgate-Palmolive, an estimated $23.7M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 18% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Hussman Strategic Advisors opened a new position in St Jude Medical worth $21.7M.

  • Hussman Strategic Advisors's largest Q4 2013 buy was St Jude Medical: 350,000 shares worth $21.7M.
  • Hussman Strategic Advisors added most to GSK in Q4 2013, an estimated $20.7M increase.
  • Hussman Strategic Advisors's biggest Q4 2013 reduction was Aflac, cutting an estimated $29.5M.
  • Hussman Strategic Advisors fully exited Colgate-Palmolive in Q4 2013, selling an estimated $23.7M.
  • Hussman Strategic Advisors's ten largest holdings make up 16% of its $1.4B portfolio in Q4 2013.
  • Hussman Strategic Advisors opened 35 new positions and closed 45 in Q4 2013.
  • Hussman Strategic Advisors's portfolio value fell 23% quarter-over-quarter to $1.4B.

Based on Hussman Strategic Advisors's 13F filing for Q4 2013, filed 11 Feb 2014.